- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 4th, 2005
When companies partner with one another, it is with the expectation that each has a role to play. Each is expected to perform its part conscientiously and expeditiously. When one partner doesn't hold up its end of the bargain, it results in delays, lost opportunities and, most importantly for companies, lost revenues.
Such is the case with the just-severed deal between pharmaceutical Biovail and nanotech developer Flamel.
|Related News Press|
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
Squeezed quantum cats May 28th, 2015
New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015
Collaboration could lead to biodegradable computer chips May 28th, 2015